23 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 23 of 23 clinical reviews.
A clinician-level review of isotretinoin use after bariatric surgery, covering altered absorption, dosing adjustments, iPLEDGE requirements, lipid monitoring, and case-specific considerations for Roux-en-Y and sleeve gastrectomy patients.
A clinician-level review of how isotretinoin affects appetite, hunger hormones, blood sugar, and food cravings, with primary-literature citations and practical management guidance.
A physician-level review of isotretinoin's autoimmune effects: documented risks, mechanistic evidence, monitoring protocols, and clinical decision-making for patients with pre-existing autoimmune conditions.
A deep dive into how isotretinoin affects bone mineral density, growth plates, and fracture risk. Covers clinical evidence, monitoring protocols, and who faces the highest risk.
A board-reviewed, primary-literature analysis of every cancer signal linked to isotretinoin: skin malignancy, colorectal cancer, hematologic risk, and the protective data. Includes FDA labeling, trial citations, and clinical guidance.
A thorough clinical review of isotretinoin's long-term cardiovascular effects, covering lipid changes, arterial stiffness, arrhythmia risk, and monitoring protocols based on primary literature and current prescribing guidelines.
A thorough clinical review of isotretinoin's effects on cognition, mood, and brain function, covering mechanisms, trial data, depression risk, and what patients and prescribers need to know.
A comparison of compounded isotretinoin versus branded Accutane and generics, covering bioavailability, FDA oversight, iPLEDGE requirements, dosing strategy, and when each formulation may be appropriate.
A comprehensive, evidence-based review of isotretinoin's effects on hair and skin, including dryness, telogen effluvium, barrier disruption, and long-term outcomes, with primary-literature citations throughout.
A guide to how isotretinoin affects liver enzymes, triglycerides, and hepatic function, including monitoring protocols, dose adjustments, and when to stop treatment.
A guide to how isotretinoin is absorbed, metabolized, and excreted, plus what current evidence says about its effects on thermogenesis, lipid handling, and energy expenditure.
A primary-literature guide to isotretinoin microdosing protocols, covering dose ranges, cumulative targets, relapse rates, and how low-dose regimens compare to standard 0.5 to 1 mg/kg/day courses.
A guide to preserving muscle mass and function during isotretinoin therapy, covering myotoxicity mechanisms, creatine kinase monitoring, exercise modifications, and nutritional protocols backed by primary literature.
Evidence-based guidance on how long to hold isotretinoin before surgery, dermabrasion, laser, and other procedures, with primary-literature citations and physician commentary.
A clinician-level review of isotretinoin rebound acne after stopping: who rebounds, why it happens, how cumulative dose shapes relapse risk, and what to do if acne returns.
A clinician-level review of isotretinoin's effects on kidney function, including proteinuria risk, IgA nephropathy associations, monitoring protocols, and dose adjustments for patients with pre-existing renal disease.
A clinician-level guide to how season, UV exposure, temperature, and humidity affect isotretinoin therapy. Covers sun protection protocols, winter dryness management, cumulative dosing strategy, and iPLEDGE compliance across the calendar year.
A analysis of isotretinoin's effects on sexual function, libido, erectile function, and hormonal pathways, with primary-literature citations and clinical guidance for patients and prescribers.
A clinician-level review of how isotretinoin affects sleep architecture, REM cycles, melatonin pathways, and mood. Includes dosing context, monitoring protocols, and primary-literature citations.
A guide to managing isotretinoin dosing, iPLEDGE compliance, sun protection, and laboratory timing when crossing time zones or traveling internationally.
A week-by-week guide to the first month on isotretinoin (Accutane): initial breakout, side effects, skin changes, lab monitoring, and what actually happens at weeks 1, 2, 3, and 4.
Large studies show no clear causal link between Accutane and depression, but FDA requires monthly mood screening. See the research and warning signs.
When and how to safely restart isotretinoin after an acute illness, including dose adjustments, lab re-checks, iPLEDGE compliance, and signals that require a longer hold.